Related Experiment Video
Updated: Feb 21, 2026

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
Published on: October 16, 2021
Impact of prosthesis-patient mismatch after mitral valve replacement in rheumatic population: Does mitral position
Seung Hyun Lee1, Byung Chul Chang1, Young-Nam Youn1
1Division of Thoracic and Cardiovascular Surgery, Severance Cardiovascular Hospital, Yonsei Cardiovascular Research Institute, Yonsei University, College of Medicine, 250 Seongsanno, Seodaemun-gu, Seoul, 03722, Republic of Korea.
Background:
Prosthesis-patient mismatch (PPM) is characterised by the effects of inadequate prosthesis size relative to body surface area (BSA).The purpose of this study was to determine the impact of PPM on late clinical outcomes after mitral valve replacement (MVR) in rheumatic population.
Methods:
From 2000 to 2013, a total of 445 patients (mean age 54.2 ± 11.7 years) underwent isolated MVR (±tricuspid annuloplasty) for rheumatic disease were investigated. Effective orifice area (EOA) was determined by the continuity equation and PPM was defined as indexed EOA (EOA/BSA) ≤ 1.2 cm2/m2. Clinical and echocardiographic follow-up (mean follow up 8.7 ± 4.0 years) results were compared.
Results:
37% of patients (n = 165) had PPM. There were no significant differences in baseline and operative characteristics between patients with and without PPM except age and IEOA. A significant decrease in mean trans-valvular pressure gradient (MPG) over time following MVR, however the change of MPG showed no differences between groups (No PPM vs. PPM: 8.9 ± 4.7 mmHg → 3.6 ± 1.2 mmHg vs. 8.7 ± 4.5 mmHg → 3.8 ± 1.4 mmHg, p-value = 0.28). In all patients, there was a reduction of left atrium dimension (58.6 ± 12.0 mm → 53.2 ± 12.0 mm vs. 57.9 ± 8.9 mm → 52.2 ± 8.9 mm, p-value = 0.68) and left ventricular end diastolic diameter (49.9 ± 5.7 mm → 48.9 ± 5.7 mm vs. 49.7 ± 6.0 mm → 48.3 ± 5.0 mm, p = 0.24) without statistical significance. Freedom from TR progression rates at 3 and 5 years (99% vs.98%, 99% vs. 98%, p-value = 0.1), and overall survival rates at 3 and 5 years (97% vs. 96%, 94% vs. 94%, p-value = 0.7) were similar.
Conclusion:
This study shows that mitral PPM is not associated with atrial /ventricular remodeling and might not influence late clinical outcome including late TR progression, survival in rheumatic population.
Insights
Prosthesis-patient mismatch (PPM) after mitral valve replacement in rheumatic patients did not significantly impact long-term outcomes. This study found no association between PPM and adverse remodeling or survival rates.
Area of Science:
- Cardiovascular Surgery
- Cardiac Surgery Outcomes
- Prosthetic Heart Valves
Background:
- Prosthesis-patient mismatch (PPM) occurs when an implanted heart valve is too small for the patient's body surface area (BSA).
- Rheumatic heart disease remains a significant cause of mitral valve disease globally, necessitating mitral valve replacement (MVR).
Purpose of the Study:
- To investigate the long-term clinical outcomes in rheumatic patients undergoing MVR.
- To determine the impact of PPM on post-MVR remodeling, survival, and tricuspid regurgitation (TR) progression.
Main Methods:
- A cohort of 445 patients with rheumatic disease undergoing isolated MVR between 2000 and 2013 were analyzed.
- Effective orifice area (EOA) was measured, and PPM was defined as indexed EOA (EOA/BSA) ≤ 1.2 cm²/m².
- Clinical and echocardiographic data were collected for a mean follow-up of 8.7 years.
Main Results:
- 37% of patients experienced PPM. No significant baseline differences were observed between groups, except for age and indexed EOA.
- Both groups showed a decrease in mean trans-valvular pressure gradient (MPG) and left atrial/ventricular dimensions post-MVR, without significant inter-group differences.
- Freedom from TR progression and overall survival rates at 3 and 5 years were similar between patients with and without PPM.
Conclusions:
- Mitral valve prosthesis-patient mismatch (PPM) in rheumatic patients undergoing MVR does not appear to be associated with adverse atrial or ventricular remodeling.
- PPM did not significantly influence late clinical outcomes, including survival and tricuspid regurgitation progression.
More Related Videos
12:17Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots
Published on: May 21, 2017
07:42An Image Guided Transapical Mitral Valve Leaflet Puncture Model of Controlled Volume Overload from Mitral Regurgitation in the Rat
Published on: May 19, 2020
Related Concept Videos
Mitral Valve Prolapse I: Introduction
Mitral Stenosis I: Introduction
Mitral Stenosis III: Medical Management
Mitral Valve Prolapse II: Assessment and Management
Mitral Regurgitation I: Introduction
Mitral Stenosis IV: Nursing Management